Hospital Universitario IRCCS San Raffaele

Ospedale San Raffaele is a premier clinical research hospital in Milan, Italy, recognized globally for its leadership in gene and cell therapy. As an Institute for Research and Care (IRCCS), it combines high-level medical treatment with cutting-edge translational research, particularly through the San Raffaele Telethon Institute for Gene Therapy (SR-TIGET). The institution is credited with developing the world's first ex vivo gene therapies to reach the market, including Strimvelis and Libmeldy. It operates as part of the Gruppo San Donato and maintains a close academic partnership with the Università Vita-Salute San Raffaele. The hospital's research pipeline covers a broad spectrum of therapeutic areas, including oncology, rare genetic diseases, neuroscience, and metabolic disorders.